Atanasio Pandiella
Atanasio Pandiella
profesor de investigación del CSIC
No verified email
Title
Cited by
Cited by
Year
Membrane-anchored growth factors
J Massague, A Pandiella
Annual review of biochemistry 62 (1), 515-541, 1993
8441993
Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies
J Baselga, L Norton, H Masui, A Pandiella, K Coplan, WH Miller Jr, ...
JNCI: Journal of the National Cancer Institute 85 (16), 1327-1333, 1993
5351993
Sox2 expression in breast tumours and activation in breast cancer stem cells
O Leis, A Eguiara, E Lopez-Arribillaga, MJ Alberdi, S Hernandez-Garcia, ...
Oncogene 31 (11), 1354-1365, 2012
4432012
Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: a potential role in regulated shedding
E Díaz-Rodríguez, JC Montero, A Esparís-Ogando, L Yuste, A Pandiella
Molecular biology of the cell 13 (6), 2031, 2002
3572002
The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance
P Maiso, X Carvajal-Vergara, EM Ocio, R López-Pérez, G Mateo, ...
Cancer research 66 (11), 5781-5789, 2006
2602006
Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process
A Pandiella, J Massague
Proceedings of the National Academy of Sciences 88 (5), 1726-1730, 1991
2301991
Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors
JC Montero, S Seoane, A Ocaña, A Pandiella
Clinical cancer research 17 (17), 5546-5552, 2011
2252011
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
B Blanco, JA Pérez-Simón, LI Sánchez-Abarca, X Carvajal-Vergara, ...
Blood 107 (9), 3575-3583, 2006
2192006
Preclinical development of molecular-targeted agents for cancer
A Ocana, A Pandiella, LL Siu, IF Tannock
Nature reviews Clinical oncology 8 (4), 200-209, 2011
2072011
Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme
JC Montero, L Yuste, E Dı́az-Rodrı́guez, A Esparı́s-Ogando, A Pandiella
Molecular and Cellular Neuroscience 16 (5), 631-648, 2000
1972000
Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2
A Esparís-Ogando, E Díaz-Rodríguez, JC Montero, L Yuste, P Crespo, ...
Molecular and cellular biology 22 (1), 270-285, 2002
1922002
Transforming growth factor β engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab
SE Wang, B Xiang, M Guix, MG Olivares, J Parker, CH Chung, ...
Molecular and cellular biology 28 (18), 5605-5620, 2008
1682008
HER3 overexpression and survival in solid tumors: a meta-analysis
A Ocana, F Vera-Badillo, B Seruga, A Templeton, A Pandiella, E Amir
JNCI: Journal of the National Cancer Institute 105 (4), 266-273, 2013
1662013
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups
A Bacigalupo, G Socié, H Schrezenmeier, A Tichelli, A Locasciulli, ...
haematologica 97 (8), 1142-1148, 2012
156*2012
Generation of inositol phosphates, cytosolic Ca2+, and ionic fluxes in PC12 cells treated with bradykinin.
C Fasolato, A Pandiella, J Meldolesi, T Pozzan
Journal of Biological Chemistry 263 (33), 17350-17359, 1988
1511988
In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
EM Ocio, D Vilanova, P Atadja, P Maiso, E Crusoe, D Fernández-Lázaro, ...
haematologica 95 (5), 794-803, 2010
1492010
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
EM Ocio, MV Mateos, P Maiso, A Pandiella, JF San-Miguel
The lancet oncology 9 (12), 1157-1165, 2008
1482008
Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor.
A Pandiella, J Massague
Journal of Biological Chemistry 266 (9), 5769-5773, 1991
1481991
Genetic abnormalities and patterns of antigenic expression in multiple myeloma
G Mateo, M Castellanos, A Rasillo, NC Gutiérrez, MA Montalbán, ...
Clinical Cancer Research 11 (10), 3661-3667, 2005
1402005
The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGFα into soluble growth factor
MW Bosenberg, A Pandiella, J Massagué
Cell 71 (7), 1157-1165, 1992
1361992
The system can't perform the operation now. Try again later.
Articles 1–20